How Pre-Existing Drugs May Help Fight Multiple Sclerosis

Ultimately, researchers settled on the antidepressant clomipramine sold under the brand name Anafranil. Researchers noted that the drug is very well tolerated and can effectively cross the blood-brain barrier. One of the benefits of using a drug that has already been approved for human use is that researchers are well aware of the potential side effects on patients, even in long term situations. Researchers then have the opportunity to weigh the possibility of different side effects against the possible advantages the drug can offer MS patients in order to determine if it will be an effective treatment choice or not.